Regulation, regulatory activities, and function of biglycan
- PMID: 15663360
- DOI: 10.1615/critreveukaryotgeneexpr.v14.i4.50
Regulation, regulatory activities, and function of biglycan
Abstract
Biglycan is a member of the small leucine repeat proteoglycan family (SLRP). The biglycan gene is located on the X chromosome. Based on the amino acid sequence, the protein core of biglycan can be divided into six distinct domains: (1) a signal sequence, (2) a propeptide region, (3) a N-terminal glycosaminoglycan attachment region, (4) a cysteine loop, followed by (5) a leucine- rich repeat region domain (that makes up over 66% of the core protein), and (6) a final cysteine loop. Biglycan has been found in almost every organ within our body, but it is not uniformly distributed within an organ. Biglycan has been shown to be expressed on the cell surface, pericellularly, and sometimes within the extracellular matrices of a range of specialized cell types within the organ. Its expression pattern has been shown to be altered by growth factors and certain pathologic conditions. The regulation of biglycan expression occurs by both transcriptional and nontranscriptional mechanisms. The currently proposed biglycan functions appear to be dependent on the particular microenvironment and on the organ in question. In this review, we will focus on gene and protein structure, localization, expression, regulation, and function.
Similar articles
-
Different usage of the glycosaminoglycan attachment sites of biglycan.J Biol Chem. 2001 Apr 20;276(16):13411-6. doi: 10.1074/jbc.M009321200. Epub 2001 Jan 5. J Biol Chem. 2001. PMID: 11145959
-
Leucine-rich repeat glycoproteins of the extracellular matrix.Matrix Biol. 1998 Apr;17(1):1-19. doi: 10.1016/s0945-053x(98)90121-4. Matrix Biol. 1998. PMID: 9628249 Review.
-
Biglycan isoforms with differences in polysaccharide substitution and core protein in human lung fibroblasts.Eur J Biochem. 2002 Aug;269(15):3688-96. doi: 10.1046/j.1432-1033.2002.03058.x. Eur J Biochem. 2002. PMID: 12153565
-
Vascular smooth muscle biglycan represents a highly conserved proteoglycan within the arterial wall.Eur J Cell Biol. 1990 Dec;53(2):296-304. Eur J Cell Biol. 1990. PMID: 2081545
-
Differential roles for small leucine-rich proteoglycans in bone formation.Eur Cell Mater. 2003 Oct 6;6:12-21; discussion 21. doi: 10.22203/ecm.v006a02. Eur Cell Mater. 2003. PMID: 14562268 Review.
Cited by
-
Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells.Genes Dev. 2005 Jul 1;19(13):1596-611. doi: 10.1101/gad.1324905. Epub 2005 Jun 16. Genes Dev. 2005. PMID: 15961525 Free PMC article.
-
Proteoglycomics: recent progress and future challenges.OMICS. 2010 Aug;14(4):389-99. doi: 10.1089/omi.2009.0123. OMICS. 2010. PMID: 20450439 Free PMC article. Review.
-
The basic science of tendinopathy.Clin Orthop Relat Res. 2008 Jul;466(7):1528-38. doi: 10.1007/s11999-008-0286-4. Epub 2008 May 14. Clin Orthop Relat Res. 2008. PMID: 18478310 Free PMC article. Review.
-
Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis.Tuberculosis (Edinb). 2014 May;94(3):187-96. doi: 10.1016/j.tube.2014.01.006. Epub 2014 Feb 7. Tuberculosis (Edinb). 2014. PMID: 24629635 Free PMC article. Clinical Trial.
-
Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer.PLoS Med. 2015 Sep 1;12(9):e1001871. doi: 10.1371/journal.pmed.1001871. eCollection 2015 Sep. PLoS Med. 2015. PMID: 26327350 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous